Skip to main content
. 2012 Apr 27;118(21):5210–5216. doi: 10.1002/cncr.27556

Table 3.

Recurrent LRs Associated With Different Ancestriesa

Mutation Latin America/Caribbean (6.5%) All Other Specified Ancestries (93.5%) Pb
BRCA1 del entire gene 13 (76%) 4 (24%) <.001
BRCA1 del exons 1-2 19 (42%) 26 (58%) <.001
BRCA1 del exons 9-12 44 (88%) 6 (12%) <.001
BRCA1 del exon 14 5 (71%) 2 (29%) <.001
BRCA1 del exons 16-17 16 (76%) 5 (24%) <.001
African (7.4%) All Other Specified Ancestries (92.6%) Pb
BRCA1 del exons 1-19 6 (75%) 2 (25%) <.001
BRCA1 del exon 8 5 (71%) 2 (29%) <.001
BRCA1 dup exons 18-19 15 (100%) 0 (0%) <.001
Central/Eastern Europe (7.4%) All Other Specified Ancestries (92.6%) Pb
BRCA1 del exon 22 6 (40%) 9 (60%) <.001
Western/Northern Europe (70.8%) All Other Specified Ancestries (29.2%) Pb
BRCA1 dup exon 13 91 (91%) 9 (9%) <.001
BRCA1 del exons 14-20 13 (100%) 0 (0%) .015
BRCA1 del exon 20 19 (90%) 2 (10%) .054
BRCA1 del exons 21-24 15 (94%) 1 (6%) .052
BRCA2 del exons 1-2 11 (100%) 0 (0%) .041

BRCA1 indicates breast cancer 1, early onset gene; BRCA2 indicates breast cancer 2, early onset gene; LR, large rearrangement.

a

These data include LRs identified at least 5 times among patients who reported only one ancestry. Percentages are given after populations to indicate relative population prevalence for this analysis. Percentages are given after counts to indicate the percentage of total observations of that rearrangement represented by the count.

b

Fisher's exact test.